Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid regimens during the perioperative period of total knee arthroplasty
ChiCTR-IPR-17011848Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in knee osteoarthritis (OA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: haemoglobin level, blood loss and 14 more. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-17011848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011848.